Children Mercy Pediatric Clinical Research Unit

Kansas City, Missouri 64108

0 studies enrolling now · 2 studies all time

What they study most

Chronic Migraine, Episodic Migraine

Studies at this site

• A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine — Running, not enrolling
• A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine — Running, not enrolling